Updated Feb. 8, 2021
Currently, there are two vaccines that have received emergency use authorizations (EUA) from the Food and Drug Administration (FDA) for use in the treatment of COVID-19 in the United States. These are the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine. There are several vaccine candidates in clinical trials and all vaccine candidates are undergoing testing in large-scale clinical trials to ensure they are safe and effective (learn more about vaccine safety). On Dec. 11, 2020 the FDA issued an EUA for the Pfizer-BioNTech COVID-19 vaccine for the prevention of coronavirus disease 2019 in individuals 16 years of age and older. On Dec. 18, the FDA issued an EUA for the Moderna vaccine for the prevention of coronavirus disease 2019 in individuals 18 years and older.